Digestive and Liver Disease
2001-01-01
Metolazone-induced cholestatic liver disease.
M Gabrielli, A Gasbarrini, A Santoliquido, R Flore, E Gaetani, A Flex, P Pola
Index: Dig. Liver Dis. 33(6) , 501, (2001)
Full Text: HTML
Abstract
Related Articles:
Simultaneous determination of metolazone and losartan potassium in their binary mixtures using high-performance liquid chromatography with fluorimetric detection: application to combined tablets and spiked human plasma.
2014-08-01
[Luminescence 29(5) , 462-70, (2014)]
Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. I: Investigation of mobile phase and MS conditions.
2015-01-01
[Anal. Chim. Acta 853 , 637-46, (2014)]
[Renal effect of treatment for heart failure].
2009-02-23
[Ugeskr. Laeg. 171(9) , 718, (2009)]
Ultra high performance supercritical fluid chromatography coupled with tandem mass spectrometry for screening of doping agents. II: Analysis of biological samples.
2015-01-01
[Anal. Chim. Acta 853 , 647-59, (2014)]
Thiazide-like diuretic drug metolazone activates human pregnane X receptor to induce cytochrome 3A4 and multidrug-resistance protein 1.
2014-11-15
[Biochem. Pharmacol. 92(2) , 389-402, (2014)]